Results 51 to 60 of about 1,937,987 (265)
Journal of International Medical Research, 2023 Beta-lactam antibiotics commonly cause immune thrombocytopenia. Cross-reactivity in patients with drug-induced immune thrombocytopenia has rarely been reported. In this study, we describe the case of a 79-year-old man who developed thrombocytopenia after
Xiaoyan He +5 more
doaj +1 more source
COVID-19 vaccination associated severe immune thrombocytopenia
Experimental Hematology & Oncology, 2021 Background Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has emerged as a deadliest global pandemic after its identification in December 2019 in Wuhan, China resulting in more than three million deaths ...
Syed Tahir Ali Shah +3 more
semanticscholar +1 more source
Coagulapathies after vaccination against SARS-CoV-2 may be derived from a combination effect of SARS-CoV-2 spike protein and adenovirus vector-triggered signaling pathways [PDF]
arXiv, 2021 The novel coronavirus SARS-CoV-2 has resulted in a global pandemic with worldwide 6-digital infection rates and thousands death tolls daily. Enormeous effords are undertaken to achieve high coverage of immunization in order to reach herd immunity to stop spreading of SARS-CoV-2 infection. Several SARS-CoV-2 vaccines, based either on mRNA, viral vectors,
arxiv
Differences in clinicopathologic variables between Borrelia C6 antigen seroreactive and Borrelia C6 seronegative glomerulopathy in dogs. [PDF]
, 2019 BackgroundRapidly progressive glomerulonephritis has been described in dogs that seroreact to Borrelia burgdorferi, but no studies have compared clinicopathologic differences in Lyme-seroreactive dogs with protein-losing nephropathy (PLN) versus dogs ...
Goldstein RE +6 more
core +1 more source
Thrombosis in immune thrombocytopenia — current status and future perspectives
British Journal of Haematology, 2021 Immune thrombocytopenia (ITP) is an autoimmune disorder in which a combination of defective platelet production and enhanced clearance leads to thrombocytopenia.
D. Swan +3 more
semanticscholar +1 more source
T cell immune abnormalities in immune thrombocytopenia [PDF]
, 2014 Immune thrombocytopenia is an autoimmune disease with abnormal T cell immunity. Cytotoxic T cells, abnormal T regulatory cells, helper T cell imbalance, megakaryocyte maturation abnormalities and abnormal T cell anergy are involved in the pathogenesis of
Jun Peng +3 more
core +1 more source
British Journal of Haematology, 2020 This document aims to provide practical guidance for the assessment and management of patients with thrombocytopenia, with a particular focus on immune thrombocytopenia (ITP), during the COVID‐19 pandemic.
S. Pavord +10 more
semanticscholar +1 more source
Therapeutic Advances in Hematology, 2021 Background: Patients with immune thrombocytopenia (ITP) are at risk of bleeding and, paradoxically, thromboembolic events (TEEs), irrespective of thrombocytopenia.
N. Cooper +8 more
semanticscholar +1 more source
Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
Research and Practice in Thrombosis and Haemostasis, 2021 1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK 2Sheffield Haemophilia and Thrombosis Centre, Sheffield, UK 3Department of Haematology, Oxford University Hospitals, Oxford, UK 4Department of ...
M. Makris +4 more
semanticscholar +1 more source
Vaccine-induced thrombosis and thrombocytopenia (VITT); Exploring the unknown
Journal of Family Medicine and Primary Care, 2022 Vaccination is supposed to be the most reliable means to end the COVID 19 pandemic, but recently there have been reports of thrombosis and thrombocytopenia in patients receiving the vaccine especially ChAdOx1 nCoV-19 (AstraZeneca University of Oxford and
Ashok Sunder +3 more
doaj +1 more source